US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

700.46

-14.4271-2.02%

Number of Gainers:69

Number of Losers:78

Number of Flat:7

PE:- -

High:720.98

Open:712.79

Low:699.89

Close:714.88

Volume:270.70M

Turnover:9.71B

Market Cap:489.62B

Float Cap:371.64B

Loading ...

Sharp Therapeutics trims H1 R&D spend, raises C$1.4 million to fund genetic disease pipeline

Spero Therapeutics Launches New Jefferies ATM Equity Program

Mobix Labs - Registers 5,000,000 Shares of Class a Common Stock for Resale - SEC Filing

Obsidian Therapeutics files to sell 29.16M shares of common stock for holders

Spero Therapeutics files $300M mixed securities shelf

Xometry CTO Raghavan Vaidyanathan Sells 5,000 Shares for $483,825

Sangamo Therapeutics Signs Asset Sale Deal Amid Bankruptcy

Alzamend Neuro Announces Annual Shareholder Meeting

Electra Therapeutics Files for IPO

Robinhood Markets Inc Stock (HOOD) Closed Down by 5.01% on Aug 28: What Signal Does It Send?

Chagee (CHA) Q2 2026 Earnings Call: Profit Margin Improves as Overseas GMV Doubles

Market Chatter: Robinhood, Kalshi, Crypto.com Lose Appeals for Injunctive Relief Against Nevada Gaming Control Board

MT Newswires Live

Odds On: How to bet on the Grand Theft Auto VI hype train

agilon health (AGL) Stock May Be Below Fair Value On Raised Guidance

Simply Wall St.

Chagee Holdings Raised to Outperform from Neutral by Macquarie

Press Release: AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI

Kaltura Director Eyal Manor Sells 21,638 Shares for $33,017.89

Voss Capital Reports Flywire Share Sale Worth $2.28 Million

Coffee Chain Operator Pivots to Stabilization After Aggressive Expansion and Product Push

Biomea Fusion Completes Key Phase 2 Trial in Type 1 Diabetes: What Investors Should Watch Next

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4539/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":700.45715,"timestamp":1787947199999,"preClose":714.8842,"halted":0,"volume":270704841,"delay":0,"changeRate":-0.020181,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-14.427063,"latestTime":"08-28 16:00:00 EDT","open":712.7944,"high":720.98267,"low":699.89124,"amount":9711714940.091192,"amplitude":0.029503,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.533593,"peRate":151.680589,"turnoverRate":0.02088,"increases":69,"decrements":78,"flats":4,"marketCap":489623304100.625,"floatMarketCap":371636161666.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":720.98267,"amplitude":0.029503,"preClose":714.8842,"low":699.89124,"pbRate":"5.533593","latestPrice":700.45715,"volume":270704841,"delay":0,"open":712.7944,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":700.9769,"twentyDayClose":673.0273,"sixtyDayClose":726.7573,"secType":"PLATE","market":"US","turnoverRate":0.02088,"peRate":151.680589,"marketCap":489623304100.625,"floatMarketCap":371636161666.625,"timestamp":1787947199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":69,"down":78,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663016694","title":"Sharp Therapeutics trims H1 R&D spend, raises C$1.4 million to fund genetic disease pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016694?lang=en_us&edition=fundamental","pubTime":"2026-08-29 06:14","pubTimestamp":1787955267,"startTime":"0","endTime":"0","summary":"Sharp Therapeutics Corp. ( ($TSE:SHRX) ) just unveiled an announcement. Sharp Therapeutics Corp. reported first-half 2026 results highlighting cont...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sharp-therapeutics-trims-h1-rd-spend-raises-c1-4-million-to-fund-genetic-disease-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sharp-therapeutics-trims-h1-rd-spend-raises-c1-4-million-to-fund-genetic-disease-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016669","title":"Spero Therapeutics Launches New Jefferies ATM Equity Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016669?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:47","pubTimestamp":1787953672,"startTime":"0","endTime":"0","summary":"The latest update is out from Spero Therapeutics ( ($SPRO) ). On August 28, 2026, Spero Therapeutics, Inc. entered into a new Open Market Sale Agre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/spero-therapeutics-launches-new-jefferies-atm-equity-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/spero-therapeutics-launches-new-jefferies-atm-equity-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","EQR","BK4588","REZ","LENZ","BK4139","BK4007","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015740","title":"Mobix Labs - Registers 5,000,000 Shares of Class a Common Stock for Resale - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015740","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015740?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:35","pubTimestamp":1787952901,"startTime":"0","endTime":"0","summary":"BRIEF-Mobix Labs - Registers 5,000,000 Shares Of Class A Common Stock For Resale - SEC FilingAug 28 (Reuters)-MOBIX LABS, INC.MOBX.O:MOBIX LABS - REGISTERS 5,000,000 SHARES OF CLASS A COMMON STOCK FOR RESALE - SEC FILINGSource text: []Further company coverage:MOBX.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P20H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4141","MOBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015282","title":"Obsidian Therapeutics files to sell 29.16M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015282","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015282?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:15","pubTimestamp":1787951716,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 29.16M shares of common stock. The company is not ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/obsidian-therapeutics-files-to-sell-29-16m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/obsidian-therapeutics-files-to-sell-29-16m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663258015","title":"Spero Therapeutics files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2663258015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663258015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:10","pubTimestamp":1787951414,"startTime":"0","endTime":"0","summary":"17:05 EDT Spero Therapeutics (SPRO) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spero-therapeutics-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spero-therapeutics-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139","SPRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663159730","title":"Xometry CTO Raghavan Vaidyanathan Sells 5,000 Shares for $483,825","url":"https://stock-news.laohu8.com/highlight/detail?id=2663159730","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663159730?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:01","pubTimestamp":1787950911,"startTime":"0","endTime":"0","summary":"Xometry CTO Raghavan Vaidyanathan sells 5,000 shares for $483,825Xometry Chief Technology Officer Raghavan Vaidyanathan sold 5,000 Class A common shares on Aug. 27, 2026.The shares were sold at USD 96","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL7TkdZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Xometry CTO Raghavan Vaidyanathan Sells 5,000 Shares for $483,825","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","BK4122","PRNT","XMTR","BK4539","LU1878469433.USD","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015983","title":"Sangamo Therapeutics Signs Asset Sale Deal Amid Bankruptcy","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015983","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015983?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:56","pubTimestamp":1787950571,"startTime":"0","endTime":"0","summary":"Sangamo Therapeutics ( ($SGMOQ) ) has provided an announcement. On June 23, 2026, Sangamo Therapeutics filed for Chapter 11 bankruptcy protection i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sangamo-therapeutics-signs-asset-sale-deal-amid-bankruptcy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sangamo-therapeutics-signs-asset-sale-deal-amid-bankruptcy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139","DADS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013080","title":"Alzamend Neuro Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013080?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:31","pubTimestamp":1787949091,"startTime":"0","endTime":"0","summary":"Alzamend Neuro announces annual shareholder meetingAlzamend Neuro plans a virtual annual shareholder meeting on Oct. 19, 2026.Shareholders will vote to elect six directors to serve until the 2028 annu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1Tpq2R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013267","title":"Electra Therapeutics Files for IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013267","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013267?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:17","pubTimestamp":1787948220,"startTime":"0","endTime":"0","summary":"Electra Therapeutics filed for an initial public offering.The late clinical-stage biopharmaceutical company did not say how many shares it intends to list, or at what price, according to a Friday fili","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","REDS","BK4127","IPOS","KCE","LENZ","FRHC","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663132430","title":"Robinhood Markets Inc Stock (HOOD) Closed Down by 5.01% on Aug 28: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663132430","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663132430?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:15","pubTimestamp":1787948127,"startTime":"0","endTime":"0","summary":"• Robinhood experienced downward pressure due to profit-taking following a multi-week rally.\n• Elevated valuation multiples and insider stock sales added short-term selling pressure.\n• Core fundamentals remain supported by expanding transaction categories and solid asset inflows.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262139387-market-movers-hood-20260828","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOX","HOOI","HOOW","HOOD","BPAY","HOII","BLCK","HOOZ","IAI","HOOC","FINX","HODU","CRPT","LU1861559042.SGD","BK4127","HOYY","HOOG","BK4547","LU1861558580.USD","BK4539","HOOY","ROBN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013210","title":"Chagee (CHA) Q2 2026 Earnings Call: Profit Margin Improves as Overseas GMV Doubles","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013210","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:00","pubTimestamp":1787947234,"startTime":"0","endTime":"0","summary":"Chagee Q2 2026 revenue rose 2.5% to RMB 3.415 billion as margins improved and overseas GMV surged 114.3%, while Greater China remained softer.","market":"sg","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/trader4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/trader4.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/transcripts/262139363-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU0348766576.USD","BK4209","CHA","LU0348767384.USD","BK4526","BK4610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013603","title":"Market Chatter: Robinhood, Kalshi, Crypto.com Lose Appeals for Injunctive Relief Against Nevada Gaming Control Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013603","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013603?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:54","pubTimestamp":1787946862,"startTime":"0","endTime":"0","summary":"Robinhood Markets , Kalshi and Crypto.com's requests for injunctive relief against the Nevada Gaming Control Board were rejected by the Ninth Circuit Court of Appeals, concluding that sports-related event contracts are not regulated by the federal government, multiple news outlets reported Friday.The appeals sought to prevent Nevada from stopping prediction market platforms from operating, which the state categorizes as gambling offerings outside of the Gaming Control Board's framework, CNBC reported.While states argue sports event contracts are essentially sports betting, prediction market providers, backed by the US Commodity Futures Trading Commission, claim their event contracts are hedging derivatives on federally regulated platforms under the Commodity Exchange Act, Bloomberg Law said.Robinhood Markets, Kalshi, and Crypto.com did not immediately respond to requests for comment from MT Newswires.Price: 104.33, Change: -5.43, Percent Change: -4.95","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HOOW","HOOY","HOOD","BPAY","HOII","HODU","IAI","HOOC","BK4547","CRPT","HOOX","BK4539","FINX","LU1861558580.USD","HOYY","HOOI","LU1861559042.SGD","BLCK","BK4127","HOOG","HOOZ","ROBN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013925","title":"Odds On: How to bet on the Grand Theft Auto VI hype train","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013925?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:40","pubTimestamp":1787946024,"startTime":"0","endTime":"0","summary":"“Odds On” is The Fly’s weekly series diving into the most interesting bets on events trading platforms like Polymarket, Kalshi, and Robinhood. Subs...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/odds-on-how-to-bet-on-the-grand-theft-auto-vi-hype-train-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/odds-on-how-to-bet-on-the-grand-theft-auto-vi-hype-train-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HOOW","HOOX","BK4539","HOOI","HOOY","FINX","HODU","BK4547","CRPT","HOOZ","LU1861559042.SGD","HOYY","HOOC","HOOG","LU1861558580.USD","IAI","ROBN","BPAY","BK4127","HOOD","BLCK","HOII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013965","title":"agilon health (AGL) Stock May Be Below Fair Value On Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013965","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013965?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:29","pubTimestamp":1787945393,"startTime":"0","endTime":"0","summary":"Agilon health stock has had a very strong year so far, yet the valuation checks still point to shares screening cheap on several measures. For investors looking at agilon health today, the combination of a sharp year to date gain and a high value score raises questions about how much upside, if any, is already reflected in the price.\n\nYear to date, agilon health is up about 459%, which is an unusually large move that can leave the stock more sensitive to shifts in expectations.\nRecent news...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/agilon-health-agl-stock-may-be-below-fair-value-on-raised-gu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/agilon-health-agl-stock-may-be-below-fair-value-on-raised-gu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGL","BK7136","BK4539","BK4196","AGL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018036","title":"Chagee Holdings Raised to Outperform from Neutral by Macquarie","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018036?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:06","pubTimestamp":1787943960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CHA/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","BK4610","BK4526","LU0348767384.USD","BK4539","CHA","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018141","title":"Press Release: AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018141","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018141?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:28","pubTimestamp":1787941680,"startTime":"0","endTime":"0","summary":"NEW YORK CITY and NEW ORLEANS, Aug. 28, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (\"KSF\") are investigating the pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018607","title":"Kaltura Director Eyal Manor Sells 21,638 Shares for $33,017.89","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018607","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018607?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:13","pubTimestamp":1787940789,"startTime":"0","endTime":"0","summary":"Kaltura director Eyal Manor sells 21,638 shares for $33,017.89Kaltura director Eyal Manor sold 21,638 common shares on Aug. 26, 2026 at a weighted average price of USD 1.53.Holdings fell to 270,760 sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4LYvzW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kaltura Director Eyal Manor Sells 21,638 Shares for $33,017.89","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTR","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663090085","title":"Voss Capital Reports Flywire Share Sale Worth $2.28 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663090085","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663090085?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:31","pubTimestamp":1787938319,"startTime":"0","endTime":"0","summary":"Voss Capital reports Flywire share sale worth $2.28 millionVoss Capital, a 10% owner of Flywire Corp, disclosed sales of voting common stock on Aug. 26-27.Sales totaled 120,021 shares at weighted aver","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL5Vlz5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Voss Capital Reports Flywire Share Sale Worth $2.28 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLYW","BK4535","LU1815336091.USD","BK4227","BK4539","BK4106","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182180993","title":"Coffee Chain Operator Pivots to Stabilization After Aggressive Expansion and Product Push","url":"https://stock-news.laohu8.com/highlight/detail?id=1182180993","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182180993?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:03","pubTimestamp":1787936589,"startTime":"0","endTime":"0","summary":"The management of Chagee Holdings Limited has defined 2026 as a year dedicated to structural adjustment and stabilization. The second-quarter results indicate that this restructuring effort has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","BK4539","LU0348766576.USD","BK4526","CHA","BK4610","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663972420","title":"Biomea Fusion Completes Key Phase 2 Trial in Type 1 Diabetes: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2663972420","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663972420?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934613,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc ($BMEA) announced an update on their ongoing clinical study. Biomea Fusion Inc. has completed a mid-stage study of BMF-219 in adu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-key-phase-2-trial-in-type-1-diabetes-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-key-phase-2-trial-in-type-1-diabetes-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4211","ISBC","BK4539","BMEA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":2,"totalSize":780,"code":"91000000","status":"200"}]}}